ReviewCurrent hematologic malignancy reports2022

CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions.

Emilia Scalzulli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.